194 related articles for article (PubMed ID: 16238314)
1. Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities.
Izumi M; Wada K; Yuasa H; Hashimoto H
J Org Chem; 2005 Oct; 70(22):8817-24. PubMed ID: 16238314
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of CMP-9''-modified-sialic acids as donor substrate analogues for mammalian and bacterial sialyltransferases.
Kajihara Y; Kamitani T; Sato R; Kamei N; Miyazaki T; Okamoto R; Sakakibara T; Tsuji T; Yamamoto T
Carbohydr Res; 2007 Sep; 342(12-13):1680-8. PubMed ID: 17572399
[TBL] [Abstract][Full Text] [Related]
3. Systematic syntheses and inhibitory activities of bisubstrate-type inhibitors of sialyltransferases.
Hinou H; Sun XL; Ito Y
J Org Chem; 2003 Jul; 68(14):5602-13. PubMed ID: 12839452
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of bisubstrate analogues targeting alpha-1,3-fucosyltransferase and their activities.
Izumi M; Kaneko S; Yuasa H; Hashimoto H
Org Biomol Chem; 2006 Feb; 4(4):681-90. PubMed ID: 16467942
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of flavonoids as sialyltransferase inhibitors.
Hidari KI; Oyama K; Ito G; Nakayama M; Inai M; Goto S; Kanai Y; Watanabe K; Yoshida K; Furuta T; Kan T; Suzuki T
Biochem Biophys Res Commun; 2009 May; 382(3):609-13. PubMed ID: 19303395
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of Pasteurella multocida sialyltransferase complexes with acceptor and donor analogues reveal substrate binding sites and catalytic mechanism.
Ni L; Chokhawala HA; Cao H; Henning R; Ng L; Huang S; Yu H; Chen X; Fisher AJ
Biochemistry; 2007 May; 46(21):6288-98. PubMed ID: 17487984
[TBL] [Abstract][Full Text] [Related]
7. Sialyltransferase inhibition and recent advances.
Wang L; Liu Y; Wu L; Sun XL
Biochim Biophys Acta; 2016 Jan; 1864(1):143-53. PubMed ID: 26192491
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a fluorescently tagged sialic acid analogue useful for live-cell imaging.
Suzuki K; Ohtake A; Ito Y; Kanie O
Chem Commun (Camb); 2012 Oct; 48(78):9744-6. PubMed ID: 22914432
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic study of CMP-Neu5Ac hydrolysis by α2,3-sialyltransferase from Pasteurella dagmatis.
Schmölzer K; Luley-Goedl C; Czabany T; Ribitsch D; Schwab H; Weber H; Nidetzky B
FEBS Lett; 2014 Aug; 588(17):2978-84. PubMed ID: 24945729
[TBL] [Abstract][Full Text] [Related]
10. Characterization of two glycolipid: alpha 2-3sialyltransferases, SAT-3 (CMP-NeuAc:nLcOse4Cer alpha 2-3sialyltransferase) and SAT-4 (CMP-NeuAc:GgOse4Cer alpha 2-3sialyltransferase), from human colon carcinoma (Colo 205) cell line.
Basu SS; Basu M; Li Z; Basu S
Biochemistry; 1996 Apr; 35(16):5166-74. PubMed ID: 8611500
[TBL] [Abstract][Full Text] [Related]
11. Potential sialyltransferase inhibitors based on neuraminyl substitution by hetaryl rings.
Mathew B; Schmidt RR
Carbohydr Res; 2007 Feb; 342(3-4):558-66. PubMed ID: 16989791
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CMP-N-acetylneuraminic acid:lactosylceramide sialyltransferase by nucleotides, nucleotide sugars and nucleotide dialdehydes.
Cambron LD; Leskawa KC
Biochem Biophys Res Commun; 1993 Jun; 193(2):585-90. PubMed ID: 8512559
[TBL] [Abstract][Full Text] [Related]
13. Highly Substituted Cyclopentane-CMP Conjugates as Potent Sialyltransferase Inhibitors.
Li W; Niu Y; Xiong DC; Cao X; Ye XS
J Med Chem; 2015 Oct; 58(20):7972-90. PubMed ID: 26406919
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic synthesis and properties of glycoconjugates with legionaminic acid as a replacement for neuraminic acid.
Watson DC; Leclerc S; Wakarchuk WW; Young NM
Glycobiology; 2011 Jan; 21(1):99-108. PubMed ID: 20978010
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis of the sialyltransferase CstII from Campylobacter jejuni in complex with a substrate analog.
Chiu CP; Watts AG; Lairson LL; Gilbert M; Lim D; Wakarchuk WW; Withers SG; Strynadka NC
Nat Struct Mol Biol; 2004 Feb; 11(2):163-70. PubMed ID: 14730352
[TBL] [Abstract][Full Text] [Related]
16. Production of cytidine 5'-monophosphate N-acetylneuraminic acid using recombinant Escherichia coli as a biocatalyst.
Lee SG; Lee JO; Yi JK; Kim BG
Biotechnol Bioeng; 2002 Dec; 80(5):516-24. PubMed ID: 12355462
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a bisubstrate analogue targeting estrogen sulfotransferase.
Armstrong JI; Verdugo DE; Bertozzi CR
J Org Chem; 2003 Jan; 68(1):170-3. PubMed ID: 12515476
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Bacterial α(2,6)-Sialyltransferase Reaction through an Inhibition of Its Inherent Sialidase Activity by Dephosphorylation of Cytidine-5'-Monophosphate.
Kang JY; Lim SJ; Kwon O; Lee SG; Kim HH; Oh DB
PLoS One; 2015; 10(7):e0133739. PubMed ID: 26231036
[TBL] [Abstract][Full Text] [Related]
19. A recombinant α-(2→3)-sialyltransferase with an extremely broad acceptor substrate specificity from Photobacterium sp. JT-ISH-224 can transfer N-acetylneuraminic acid to inositols.
Mine T; Miyazaki T; Kajiwara H; Tateda N; Ajisaka K; Yamamoto T
Carbohydr Res; 2010 Nov; 345(17):2485-90. PubMed ID: 20947069
[TBL] [Abstract][Full Text] [Related]
20. Lithocholic acid analogues, new and potent alpha-2,3-sialyltransferase inhibitors.
Chang KH; Lee L; Chen J; Li WS
Chem Commun (Camb); 2006 Feb; (6):629-31. PubMed ID: 16446832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
